Direct sampling of a clinically visible vesiculobullous lesion.
Cutaneous and mucocutaneous lesion swab specimens using Universal Viral Transport Medium (UTM)
Specimen Collection / Processing Instructions
Aseptically remove sterile swab from package. Collect specimen by vigorously swabbing the clinically visible vesiculobullous lesion. Aseptically remove cap from vial. Place swab in transport medium and break off swab against rim of the tube. Replace cap. Label the vial with patient's name.
Complete the Incyte Diagnostics requisition with the patient's demographics and relevant clinical history. Label specimen container with the patient's full first and last name, second unique identifier, and specimen source/site.
15 days from the date of collection
Unacceptable Specimen Conditions
No swab in container, other collection medias, improperly labeled containers, past collection stability, no lesion swabbed
The ARIES® HSV 1&2 Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV 1 and HSV 2) DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients. The test is indicated for use as an aid in diagnosis of HSV infection in symptomatic patients.
1–2 business days from receipt
21 days from submission
Herpes testing is intended for use on a visible lesion. Herpes collection must be performed with a separate dedicated swab.
*The listed CPT codes are for reference use only. Final coding is based on CPT guidelines and individual circumstances.